Video surveillance for monitoring driver's fatigue and distraction

Fatigue and distraction effects in drivers represent a great risk for road safety. For both types of driver behavior problems, image analysis of eyes, mouth and head movements gives valuable information. We present in this paper a system for monitoring fatigue and distraction in drivers by evaluating their performance using image processing. We extract visual features related to nod, yawn, eye closure and opening, and mouth movements to detect fatigue as well as to identify diversion of attention from the road. We achieve an average of 98.3% and 98.8% in terms of sensitivity and specificity for detection of driver's fatigue, and 97.3% and 99.2% for detection of driver's distraction when evaluating four video sequences with different drivers

Sliding window multi-curve resolution: application to gas chromatography - ion mobility spectrometry

Blind source separation (BSS) techniques aim to extract a set of source signals from a measured mixture in an unsupervised manner. In the chemical instrumentation domain source signals typically refer to time-varying analyte concentrations, while the measured mixture is the set of observed spectra. Several techniques exist to perform BSS on ion mobility spectrometry, being simple-to-use interactive self-modelling mixture analysis (SIMPLISMA) and multivariate curve resolution (MCR) the most commonly used. The addition of a multi-capillary gas chromatography column using the ion mobility spectrometer as detector has been proposed in the past to increase chemical resolution. Short chromatography times lead to high levels of co-elution, and ion mobility spectra are key to resolve them. For the first time, BSS techniques are used to deconvolve samples of the gas chromatography-ion mobility spectrometry tandem. We propose a method to extract spectra and concentration profiles based on the application of MCR in a sliding window. Our results provide clear concentration profiles and pure spectra, resolving peaks that were not detected by the conventional use of MCR. The proposed technique could also be applied to other hyphenated instruments with similar strong co-elutions

Patrimonio natural y cultural de Tepotzotlán

324 páginas. Especialización en Diseño, Planificación y Conservación de Paisajes y Jardines.El presente documento muestra el trabajo realizado para la intervención paisajística en pueblo de Tepotzotlán. Al ser catalogado en el programa de pueblos mágicos dada su riqueza tangible e intangible; resulta relevante su estudio a fin de rescatar y/o enaltecer algunas de las virtudes que lo resguardan. La zona de intervención se enfocó esencialmente en el polígono patrimonial del centro histórico, los caminos constituidos a lo largo de Rio Chiquito y calles aledañas que conectan los tesoros patrimoniales de la zona. Dicho estudio fue abordado principalmente por grupos de trabajo interdisciplinario, conformados por alumnos de la especialidad en Paisajes y Jardines Históricos de la UAM Azcapotzalco. Se cotejaron 5 proyectos detonadores: Centro Histórico/Atrio de los Olivos, Par vial, Rio Chiquito, Camino Real de Lluvias y Acequia Real. Durante la primera etapa, se establecieron las limitaciones y potencialidades del sitio. Se recopiló información cualitativa y cuantitativa para la formulación y ejecución de un plan maestro que regirían los parámetros y objetivos en cada proyecto. El desarrollo conceptual y anteproyecto para cada zona de intervención, se reflejó en la segunda etapa de este proceso. Paralelamente, la elaboración de la propuesta de vegetación, las fichas de cada especie vegetal y la preparación de catálogos de paisaje, complementan el carácter de este trabajo. El proyecto realizado en Tepotzotlán: “Patrimonio Natural y Cultural De Tepotzotlán”, emerge, como el título del trabajo indica: desde la visión del rescate patrimonial, constituido por elementos materiales y naturales relevantes para la población local y todos sus visitantes. La última etapa comprende la puesta en marcha del proyecto ejecutivo, donde se plasmaron los detalles que dan cuerpo a cada elemento de las propuestas de diseño, la información necesaria para su construcción y la síntesis de toda la documentación consultada y elaborada, como sostén de diseño. En las siguientes páginas y capítulos, se explicará de manera extensa y particular: la metodología planteada y utilizada en el abordaje de cada proyecto. En general, se podrá observar la construcción de un trabajo paisajístico integral, llevado a cabo a lo largo de un año de esfuerzo y dedicación, vertidos en la presente tesis.Consejo Nacional de Ciencia y Tecnología (México)

Mapping of social initiatives as a model of local development against depopulation in rural areas. The Valle del Genal case (Andalusia, Spain)

The cultural heritage of many rural areas, such as the villages of Valle del Genal in Andalusia, is endangered. Factors such as the depopulation suffered in the last 25 years have prevented the knowledge transfer from the elderly to the young. This paper focuses on mapping the social, economic and habitat resources as a preliminary step to the implementation of measures and policies against the abandonment of these areas. The aim is to create a map regarding the cultural identity and idiosyncrasy of each village in the valley. The mapping of these local entities is carried out through a combination of participatory work with the communities in the area and the data tracking from geo-positioning and social networks applications. During the identification and inventory process, the relationship between different citizen initiatives and social groups are analysed. This cartography pretends to offer a base of accessible knowledge for inhabitants and visitors.Universidad de Málaga. Campus de Excelencia Internacional Andalucía Tech

Grupo español de cirugía torácica asistida por videoimagen: método, auditoría y resultados iniciales de una cohorte nacional prospectiva de pacientes tratados con resecciones anatómicas del pulmón

Introduction: our study sought to know the current implementation of video-assisted thoracoscopic surgery (VATS) for anatomical lung resections in Spain. We present our initial results and describe the auditing systems developed by the Spanish VATS Group (GEVATS). Methods: we conducted a prospective multicentre cohort study that included patients receiving anatomical lung resections between 12/20/2016 and 03/20/2018. The main quality controls consisted of determining the recruitment rate of each centre and the accuracy of the perioperative data collected based on six key variables. The implications of a low recruitment rate were analysed for '90-day mortality' and 'Grade IIIb-V complications'. Results: the series was composed of 3533 cases (1917 VATS; 54.3%) across 33 departments. The centres' median recruitment rate was 99% (25-75th:76-100%), with an overall recruitment rate of 83% and a data accuracy of 98%. We were unable to demonstrate a significant association between the recruitment rate and the risk of morbidity/mortality, but a trend was found in the unadjusted analysis for those centres with recruitment rates lower than 80% (centres with 95-100% rates as reference): grade IIIb-V OR=0.61 (p=0.081), 90-day mortality OR=0.46 (p=0.051). Conclusions: more than half of the anatomical lung resections in Spain are performed via VATS. According to our results, the centre's recruitment rate and its potential implications due to selection bias, should deserve further attention by the main voluntary multicentre studies of our speciality. The high representativeness as well as the reliability of the GEVATS data constitute a fundamental point of departure for this nationwide cohort

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR–Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes.This work has been supported by grant nos. PID2019-109087RB-I00 (to R.P.-J.) and RTI2018-101223-B-I00 and PID2021-127644OB-I00 (to L.M.) from the Spanish Ministry of Science and Innovation. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 964764 (to R.P.-J.). The content presented in this document represents the views of the authors, and the European Commission has no liability in respect to the content. We acknowledge financial support from the Spanish Foundation for the Promotion of Research of Amyotrophic Lateral Sclerosis. A.F. acknowledges Spanish Center for Biomedical Network Research on Rare Diseases (CIBERE) intramural funds (no. ER19P5AC756/2021). F.J.M.M. acknowledges research support by Conselleria d’Educació, Investigació, Cultura i Esport from Generalitat Valenciana, research project nos. PROMETEO/2017/129 and PROMETEO/2021/057. M.M. acknowledges funding from CIBERER (grant no. ER19P5AC728/2021). The work has received funding from the Regional Government of Madrid (grant no. B2017/BMD3721 to M.A.M.-P.) and from Instituto de Salud Carlos III, cofounded with the European Regional Development Fund ‘A way to make Europe’ within the National Plans for Scientific and Technical Research and Innovation 2017–2020 and 2021–2024 (nos. PI17/1659, PI20/0429 and IMP/00009; to M.A.M.-P. B.P.K. was supported by an MGH ECOR Howard M. Goodman Award and NIH P01 HL142494

Assessment of platelet REACtivity after transcatheter aortic valve replacement

OBJECTIVES: The REAC-TAVI (Assessment of platelet REACtivity after Transcatheter Aortic Valve Implantation) trial enrolled patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) pre-treated with aspirin + clopidogrel, aimed to compare the efficacy of clopidogrel and ticagrelor in suppressing high platelet reactivity (HPR) after TAVI. BACKGROUND: Current recommendations support short-term use of aspirin + clopidogrel for patients with severe AS undergoing TAVR despite the lack of compelling evidence. METHODS: This was a prospective, randomized, multicenter investigation. Platelet reactivity was measured at 6 different time points with the VerifyNow assay (Accriva Diagnostics, San Diego, California). HPR was defined as (P2Y12 reaction units (PRU) ≥208. Patients with HPR before TAVR were randomized to either aspirin + ticagrelor or aspirin + clopidogrel for 3 months. Patients without HPR continued with aspirin + clopidogrel (registry cohort). The primary endpoint was non-HPR status (PRU <208) in ≥70% of patients treated with ticagrelor at 90 days post-TAVR. RESULTS: A total of 68 patients were included. Of these, 48 (71%) had HPR (PRU 273 ± 09) and were randomized to aspirin + ticagrelor (n = 24, PRU 277 ± 08) or continued with aspirin + clopidogrel (n = 24, PRU 269 ± 49). The remaining 20 patients (29%) without HPR (PRU 133 ± 12) were included in the registry. Overall, platelet reactivity across all the study time points after TAVR was lower in patients randomized to ticagrelor compared with those treated with clopidogrel, including those enrolled in the registry (p < 0.001). The primary endpoint was achieved in 100% of patients with ticagrelor compared with 21% with clopidogrel (p < 0.001). Interestingly, 33% of clopidogrel responder patients at baseline developed HPR status during the first month after TAVR. CONCLUSIONS: HPR to clopidogrel is present in a considerable number of patients with AS undergoing TAVR. Ticagrelor achieves a better and faster effect, providing sustained suppression of HPR to these patients. (Platelet Reactivity After TAVI: A Multicenter Pilot Study [REAC-TAVI]; NCT02224066)

Assessment of Platelet REACtivity After Transcatheter Aortic Valve Replacement: The REAC-TAVI Trial

OBJECTIVES: The REAC-TAVI (Assessment of platelet REACtivity after Transcatheter Aortic Valve Implantation) trial enrolled patients with aortic stenosis (AS) undergoing transcatheter aortic valve replacement (TAVR) pre-treated with aspirin + clopidogrel, aimed to compare the efficacy of clopidogrel and ticagrelor in suppressing high platelet reactivity (HPR) after TAVI. BACKGROUND: Current recommendations support short-term use of aspirin + clopidogrel for patients with severe AS undergoing TAVR despite the lack of compelling evidence. METHODS: This was a prospective, randomized, multicenter investigation. Platelet reactivity was measured at 6 different time points with the VerifyNow assay (Accriva Diagnostics, San Diego, California). HPR was defined as (P2Y12 reaction units (PRU) ≥208. Patients with HPR before TAVR were randomized to either aspirin + ticagrelor or aspirin + clopidogrel for 3 months. Patients without HPR continued with aspirin + clopidogrel (registry cohort). The primary endpoint was non-HPR status (PRU <208) in ≥70% of patients treated with ticagrelor at 90 days post-TAVR. RESULTS: A total of 68 patients were included. Of these, 48 (71%) had HPR (PRU 273 ± 09) and were randomized to aspirin + ticagrelor (n = 24, PRU 277 ± 08) or continued with aspirin + clopidogrel (n = 24, PRU 269 ± 49). The remaining 20 patients (29%) without HPR (PRU 133 ± 12) were included in the registry. Overall, platelet reactivity across all the study time points after TAVR was lower in patients randomized to ticagrelor compared with those treated with clopidogrel, including those enrolled in the registry (p < 0.001). The primary endpoint was achieved in 100% of patients with ticagrelor compared with 21% with clopidogrel (p < 0.001). Interestingly, 33% of clopidogrel responder patients at baseline developed HPR status during the first month after TAVR. CONCLUSIONS: HPR to clopidogrel is present in a considerable number of patients with AS undergoing TAVR. Ticagrelor achieves a better and faster effect, providing sustained suppression of HPR to these patients. (Platelet Reactivity After TAVI: A Multicenter Pilot Study [REAC-TAVI]; NCT02224066)

ETOMIC advanced network monitoring system for future internet experimentation

Revised Selected Papers of 6th International ICST Conference, TridentCom 2010, Berlin, Germany, May 18-20, 2010,The final publication is available at Springer via http://dx.doi.org/10.1007/978-3-642-17851-1_20ETOMIC is a network traffic measurement platform with high precision GPS-synchronized monitoring nodes. The infrastructure is publicly available to the network research community, supporting advanced experimental techniques by providing high precision hardware equipments and a Central Management System. Researchers can deploy their own active measurement codes to perform experiments on the public Internet. Recently, the functionalities of the original system were significantly extended and new generation measurement nodes were deployed. The system now also includes well structured data repositories to archive and share raw and evaluated data. These features make ETOMIC as one of the experimental facilities that support the design, development and validation of novel experimental techniques for the future Internet. In this paper we focus on the improved capabilities of the management system, the recent extensions of the node architecture and the accompanying database solutions.The authors thank the support of the EU ICT OneLab2 Project (No.224263), the EU ICT MOMENT Project (No.215225) and the National Office for Research and Technology (NAP2005/KCKHA005

Case-Control Analysis of the Impact of Anemia on Quality of Life in Patients with Cancer: A Qca Study Analysis

The impact of anemia on the quality of life (QoL) in cancer patients has been studied previously; however, the cut-off point used to define anemia differed among studies, thus providing inconsistent results. Therefore, we analysed the clinical impact of anemia on QoL using the same cut-off point for hemoglobin level to define anemia as that used in ESMO clinical practice guidelines. This post-hoc analysis aimed to determine the impact of anemia on QoL in cancer patients through the European Organization for Research and Treatment of Cancer Quality of life questionnaire version 3.0 (EORTC QLQ-C30) and Euro QoL 5-dimension 3-level (EQ-5D-3L) questionnaire. We found that cancer patients with anemia had significantly worse QoL in clinical terms. In addition, anemic patients had more pronounced symptoms than those in non-anemic patients. Anemia is a common condition in cancer patients and is associated with a wide variety of symptoms that impair quality of life (QoL). However, exactly how anemia affects QoL in cancer patients is unclear because of the inconsistencies in its definition in previous reports. We aimed to examine the clinical impact of anemia on the QoL of cancer patients using specific questionnaires. We performed a post-hoc analysis of a multicenter, prospective, case-control study. We included patients with cancer with (cases) or without (controls) anemia. Participants completed the European Organization for Research and Treatment of Cancer Quality of Life questionnaire version 3.0 (EORTC QLQ-C30) and Euro QoL 5-dimension 3-level (EQ-5D-3L) questionnaire. Statistically significant and clinically relevant differences in the global health status were examined. From 2015 to 2018, 365 patients were included (90 cases and 275 controls). We found minimally important differences in global health status according to the EORTC QLQ-C30 questionnaire (case vs. controls: 45.6 vs. 58%, respectively; mean difference: -12.4, p < 0.001). Regarding symptoms, cancer patients with anemia had more pronounced symptoms in six out of nine scales in comparison with those without anemia. In conclusion, cancer patients with anemia had a worse QoL both clinically and statistically